BioSpace News Archive

Business

Omeros Corporation Reports Fourth Quarter and Year-End 2021 Financial Results

Omeros Corporation (Nasdaq: OMER), today announced recent highlights and developments as well as financial results for the fourth quarter and year ended December 31, 2021.

March 1, 2022
·
20 min read
BioCapital

Danaher To Present At Cowen Healthcare Conference - Mar 01, 2022

Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Cowen Healthcare Conference on Tuesday, March 8, 2022 at 9:10 a.m. ET.

March 1, 2022
·
1 min read
Venturi Mask Market: North America and Europe are projected to hold a major share of the market

When a fluid travels through an hourglass-shaped pipe, there is a reduction in pressure of the fluid in the throat of the pipe, and the velocity of the fluid increases in the throat area, this is known as the Venturi effect.

March 1, 2022
·
5 min read
Recombinant Thrombin Market: Increase in number of surgeries worldwide to drive the market

Hemostasis is the process where platelets, blood vessels, and coagulation factors act together to arrest bleeding.

March 1, 2022
·
6 min read
Radionuclide Scanner Market: Increase in Incidences of Cancer to Drive the Market

Radionuclide scan is an imaging procedure used to detect cancerous tissues in human body.

March 1, 2022
·
5 min read
Pharm Country

Halberd’s COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant

Halberd Corporation’s (OTC Pink: HALB) previously developed SARS-CoV-2 antibody demonstrated superior binding capability to the SARS-CoV-2 Omicron variant disease antigen.

March 1, 2022
·
4 min read
BioMark Provides the Third Quarter Operational Update and 2022 Outlook

BioMark completed lab equipment installation and started calibration of its system with vendors for its Quebec-based lab facilities.

March 1, 2022
·
5 min read
Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial

LANCER Trial expanded to include up to 20 Additional Clinical Research Centers.

March 1, 2022
·
7 min read
Bio NC

G1 Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference and the 34th Annual Roth 2022 Conference

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two upcoming investor conferences in March 2022.

March 1, 2022
·
1 min read
Business

Papyrus Therapeutics Announces Formation of Scientific Advisory Board

Papyrus Therapeutics Inc. announces the formation of its Scientific Advisory Board [SAB].

March 1, 2022
·
3 min read